Impel Pharmaceuticals (IMPL) Q1 2021 Earnings

7JunConfirmed
Mar 21
Apr 21
Q1 2021
-15.09
-10.06
-5.03
0

Details

Expected EPS
-0.93
Actual EPS
-15
Surprise EPS
-14.07
Surprise Percent
+1,512.9%

Description

Impel Pharmaceuticals (IMPL) has reported earnings of -15 per share for Q1 2021.

0 Comments

Share your thoughts